MicroRNAs Used in Combination with Anti-Cancer Treatments Can Enhance Therapy Efficacy
MicroRNAs (miRNAs), a recently discovered class of small non-coding RNAs, constitute a promising approach to anti-cancer treatments when they are used in combination with other agents. MiRNAs are evolutionarily conserved non-coding RNAs that negatively regulate gene expression by binding to the comp...
Main Authors: | Mognato, Maddalena, Celotti, Lucia |
---|---|
Format: | Online |
Language: | English |
Published: |
Bentham Science Publishers
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997954/ |
Similar Items
-
The Efficiency of Homologous Recombination and Non-Homologous End Joining Systems in Repairing Double-Strand Breaks during Cell Cycle Progression
by: Bee, Leonardo, et al.
Published: (2013) -
The toxicity outcome of silica nanoparticles (Ludox®) is influenced by testing techniques and treatment modalities
by: Fede, Caterina, et al.
Published: (2012) -
Integration Analysis of MicroRNA and mRNA Expression Profiles in Human Peripheral Blood Lymphocytes Cultured in Modeled Microgravity
by: Girardi, C., et al.
Published: (2014) -
MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA Expression
by: Costa, Pedro M., et al.
Published: (2013) -
Can microRNAs keep inflammasomes in check?
by: Qazi, Omar, et al.
Published: (2013)